$ADXS Advaxis, Inc. Insider Trading
Get free email notifications about insider trading in Advaxis, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Advaxis, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Advaxis, Inc. for free.
IRS Number: 841521955
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ADXS
Company Address: 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION 08852
Phone number: 732-545-1590
Former name: GREAT EXPECTATIONS & ASSOCIATES INC, date of change: 1999-12-03
Former name: GREAT EXPECTATIONS AND ASSOCIATES, INC.
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.
Market Capitalization: $360.52M
Prev close: $9.15
Average Daily Volume: 692,844
Days Low: $8.69
Year Low: $5.21
Year High: $16.30
Advaxis, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2020 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
May 05 2020 | ADXS | Advaxis, Inc. | Khleif Samir N | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
May 05 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
May 05 2020 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President and CEO | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
May 05 2020 | ADXS | Advaxis, Inc. | PATTON JAMES P | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
May 05 2020 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
May 05 2020 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
May 05 2020 | ADXS | Advaxis, Inc. | Gutierrez Andres | Executive Vice Pres ... | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
Mar 16 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Sell | S | 0.55 | 2,401 | 1,321 | 10,476 | 12.9 K to 10.5 K (-18.65 %) |
Mar 16 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Sell | S | 0.58 | 200 | 116 | 12,877 | 13.1 K to 12.9 K (-1.53 %) |
Mar 16 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Sell | S | 0.67 | 399 | 267 | 13,077 | 13.5 K to 13.1 K (-2.96 %) |
Oct 25 2019 | ADXS | Advaxis, Inc. | Gutierrez Andres | Exec VP, Chief Medi ... | Option Exercise | A | 0.31 | 25,000 | 7,750 | 25,000 | |
Oct 25 2019 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
Oct 25 2019 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
Oct 25 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 0.31 | 25,000 | 7,750 | 25,000 |